Lv3
206 积分 2024-02-03 加入
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2个月前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
2个月前
已完结
Treatment of advanced HER2-positive breast cancer: 2018 and beyond
2个月前
已完结
Breast Cancer Treatment
2个月前
已完结
Resolving HER2 status in breast carcinoma patients with complete deletion of CEP17 in fluorescence in-situ hybridization assays
3个月前
已关闭
Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration
3个月前
已关闭
Multimodal imaging characteristics of intraductal papillary neoplasms of the breast
4个月前
已关闭
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
5个月前
已完结
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis
7个月前
已完结
Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography)
7个月前
已完结
皖公网安备34019202002308
